Duvyzat vs Farydak: Side-by-Side Comparison
Quick answer: Duvyzat and Farydak are both histone deacetylase (hdac) inhibitor used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Duvyzat | Farydak |
|---|---|---|
| Drug class | Histone deacetylase (HDAC) inhibitor | Histone deacetylase (HDAC) inhibitor |
| ATC code | M09AX11 | L01XH03 |
| Primary indications | Duchenne muscular dystrophy | Multiple myeloma (relapsed/refractory) |
| Mechanism | Non-selective HDAC inhibitor (givinostat) that reduces inflammation, fibrosis, and muscle degeneration in dystrophin-deficient muscle | Pan-HDAC inhibitor that induces cell-cycle arrest and apoptosis in malignant cells |
| Common dose | Weight-based oral dosing twice daily (typical adult range 53.2-79.8 mg twice daily) | 20 mg three times weekly in 21-day cycles |
| Detail page | Duvyzat details → | Farydak details → |
How to choose between Duvyzat and Farydak
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Histone deacetylase (HDAC) inhibitor on iMedic · Duvyzat full details · Farydak full details
Frequently asked questions
Is Duvyzat better than Farydak?
Neither is universally 'better.' They are both histone deacetylase (hdac) inhibitor with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Duvyzat to Farydak?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Duvyzat and Farydak have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Duvyzat and Farydak available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.